PharmaCyte Biotech, Inc. (PMCB)
NASDAQ: PMCB · Real-Time Price · USD
1.670
-0.040 (-2.20%)
At close: Nov 21, 2024, 3:54 PM
1.750
+0.080 (4.79%)
After-hours: Nov 21, 2024, 3:56 PM EST
PharmaCyte Biotech Cash Flow Statement
Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Jul '24 Jul 31, 2024 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 | Apr '21 Apr 30, 2021 | Apr '20 Apr 30, 2020 |
| Net Income | 26.94 | 0.33 | -4.32 | -4.24 | -3.55 | -3.83 | |
| Asset Writedown & Restructuring Costs | 2 | 2 | - | - | - | - | |
| Loss (Gain) From Sale of Investments | -20.55 | 1.57 | - | - | - | - | |
| Stock-Based Compensation | 0.9 | 0.67 | 0.65 | 0.11 | 0.44 | 1.22 | |
| Other Operating Activities | -11.95 | -7.03 | 0.17 | - | -0.08 | - | |
| Change in Accounts Payable | -0.16 | 0.26 | -0.24 | 0.03 | -0.01 | 0.06 | |
| Change in Other Net Operating Assets | -0.04 | 0.04 | -0.05 | -0.02 | -0.13 | 0.2 | |
| Operating Cash Flow | -2.87 | -2.15 | -3.79 | -4.12 | -3.33 | -2.34 | |
| Other Investing Activities | -5 | -5 | - | - | - | - | |
| Investing Cash Flow | -12 | -5 | - | - | - | - | |
| Long-Term Debt Issued | - | - | - | - | - | 0.08 | |
| Total Debt Issued | - | - | - | - | - | 0.08 | |
| Long-Term Debt Repaid | - | - | - | -0.05 | -0.06 | -0.01 | |
| Total Debt Repaid | - | - | - | -0.05 | -0.06 | -0.01 | |
| Net Debt Issued (Repaid) | - | - | - | -0.05 | -0.06 | 0.06 | |
| Issuance of Common Stock | - | 0 | 0 | 87.36 | 4.7 | 2.66 | |
| Repurchase of Common Stock | -2.48 | -28.2 | -13.56 | - | - | - | |
| Financing Cash Flow | -27.16 | -10.71 | -13.56 | 87.31 | 4.64 | 2.73 | |
| Foreign Exchange Rate Adjustments | -0 | -0 | -0.01 | 0 | 0 | -0.01 | |
| Net Cash Flow | -42.03 | -17.86 | -17.36 | 83.2 | 1.31 | 0.38 | |
| Free Cash Flow | -2.87 | -2.15 | -3.79 | -4.12 | -3.33 | -2.34 | |
| Free Cash Flow Per Share | -0.34 | -0.22 | -0.19 | -0.27 | -2.30 | -2.59 | |
| Cash Interest Paid | - | - | - | 0 | 0 | 0 | |
| Cash Income Tax Paid | - | 0 | - | 0 | 0 | 0 | |
| Levered Free Cash Flow | 3.13 | -2.55 | -3.52 | -2.62 | -1.97 | -1.03 | |
| Unlevered Free Cash Flow | 3.13 | -2.55 | -3.52 | -2.62 | -1.97 | -1.03 | |
| Change in Net Working Capital | -5.8 | -0.85 | 0.13 | -0.01 | 0.15 | -0.14 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.